AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Jul 19, 2016
5262_dirs_2016-07-19_540888b5-06aa-4e71-8fe6-e52fa40d9cd7.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6585E
GlaxoSmithKline PLC
19 July 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr K Slaoui
b)
Position/status
PCA of Dr M M Slaoui (Chairman, Global Vaccines)
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Nature of the transaction
Increase in notional interest in ADSs following the re-investment of dividends paid to shareholders on 14 July 2016 on ADSs held in the Company's 2009 Performance Share Plan.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| $43.87 | 23.570 |
| $43.87 | 24.936 |
| $43.87 | 26.321 |
d)
Aggregated information
Aggregated volume Price
74.827 ADSs
$43.87
e)
Date of the transaction
2016-07-14
f)
Place of the transaction
n/a
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHQKLFFQDFZBBV
//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'Zbs0Fme2lyJ9suF2NFCDCrZEPHoat38o7sc9g57Jo7VXW9UrUcXTSJiW6_WqkGDusTWn53WbqfGyEI--44pO_zZ-F9RStf5RCLo3GJWwR8I1:r-m9calQ27VgFX5VE3fZik0KiZ8UsCXGFakeH3HUof7_MqPe5BTVwG7JQN1QL09MMe2nr5_Osi1Lr9b8X_wXnHONWK3qhz5fjeEBt-FOqhI1'}});//]]>